Pharmacy benefit managers and health carriers inclusion of lower-cost drugs in formularies requirement provision and lowest out-of-pocket-cost drug to patient formulary tiering preference provision

Removed the requirement to compare a drug's cost against 'any other' equivalent generic, simplifying the rule to only require inclusion if the cost is lower than the brand-name drug.

Simplified the rule for generic drugs, removing the requirement to compare their cost against the brand-name drug's cost, instead only requiring the brand to be included if it is cheaper.

Narrowed the trigger for adding new generic drugs to formularies, removing the requirement that the new generic must be cheaper than the lowest-cost generic already on the list, and requiring it only to be cheaper than the brand-name drug.

Updated the document title and posting date to reflect the bill's progression to its first engrossment version.